Midgard Science

Medreich Limited

Bengaluru, India medreich.com From their website, Nov 2026

Work here? Claim this listing

About

Medreich Limited is a pharmaceutical CMO and CDMO that develops, manufactures, and packages dosage forms for regulated and emerging markets. It serves customers in India, the UK, Australia, New Zealand, Europe, Canada, Far East Asia, GCC, Africa, LATAM, and CIS from sites in Bengaluru, Australia, and the United Kingdom.

Services

  • Proof of Concept

    Develops novel drug delivery dosage forms using broad technology platforms and smaller-scale R&D batches to assess API, salt, and polymorphic form feasibility.

  • Formulation Development

    Develops oral solid dosage forms including modified, controlled, and FDC immediate-release formulations, as well as liquids, suspensions, emulsions, semisolids, and creams.

  • Analytical Services

    Provides analytical method development, validation, technology transfer, API characterization, impurity profiling, solubility and dissolution studies, polymorphic studies, stability studies, and microbiological testing.

  • Clinical Manufacturing

    Provides cGMP manufacturing for bio batch products including tablets and capsules, and supports bioavailability and bioequivalence study design, execution, analysis, and dossier compilation.

  • Commercial Manufacturing

    Manufactures tablets, capsules, dry powders for suspensions, and dry powder for injections in six manufacturing facilities under GMP and quality management systems.

  • Packaging Design & Development

    Designs primary and secondary packaging, artwork, labeling, containerization, and anti-counterfeit features for multiple dosage forms and pack configurations.

  • Regulatory

    Supports regulatory filings in CTD format, market authorization applications, CMC documentation, product information, labeling, post-approval maintenance, variations, and renewals.

  • Pharmacovigilance

    Processes adverse event cases, including triage, case entry, follow-up, narrative writing, quality review, medical review, PSUR compilation, signal detection, and risk-benefit analysis.

What to send
API / salt / polymorphic form for proof of concept studies

Capabilities

Assays and studies
  • Analytical development
  • Stability studies
  • Analytical method development
  • Method validation
  • Technology transfer
  • API characterization
10 more
  • Impurity profiling
  • Solubility studies
  • Dissolution studies
  • Multi-media dissolution
  • Diffusion studies
  • Polymorphic studies
  • Photo stability studies
  • Microbiological testing
  • Bioavailability studies
  • Analytical method validation
Scale and capacity
  • Smaller scale R&D batches
  • Batch sizes ranging from a few thousand units to over a million units per batch
  • Six state of the art manufacturing facilities
  • Two stability centers equipped with walk-in chambers
  • A team of 45+ regulatory experts
  • Close to 4000 employees worldwide
  • Six manufacturing facilities
Therapeutic areas
Diverse therapeutic categories

Modalities and species

Modalities
Small molecule

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: Clinical manufacturing and commercial manufacturing

Industries served

  • Pharmaceuticals

Company

Type
CDMO
Founded
2015
Size
1001-5000 employees
Quality
cGMP (Bio Batch products) · GMP (manufacturing facilities) · ICH (stability studies and bioequivalence studies) · QMS (all units) · eQMS (quality management system) · QLMS (quality control laboratory management) · USFDA (bioequivalence study site inspection context) · UK MHRA (manufacturing facility approval context) · TGA Australia (manufacturing facility approval context) · Health Canada (manufacturing facility approval context) · PMDA Japan (manufacturing facility approval context) · MFDS South Korea (manufacturing facility approval context) · MCC South Africa (manufacturing facility approval context) · PICS (manufacturing facility compliance context) · ICH guidelines (Stability studies and bioequivalence studies) · Current Good Clinical Practices (Bioequivalence studies) · Good Laboratory practices (Bioequivalence studies)

Locations

Office
21 Underwood Road, Homebush Business Village Homebush New South Wales 2140 Australia
Sites
  • Homebush, Australia
  • Feltham London, United Kingdom
  • Feltham, United Kingdom
Serves
India, Japan, Australia & New Zealand, United Kingdom, Rest of Europe, Canada, Far East Asia, GCC, Africa, LATAM, CIS

Contacts

Similar labs